AGI grade-guided chaiqin chengqi decoction treatment for predicted moderately severe and severe acute pancreatitis (CAP trial): study protocol of a randomised, double-blind, placebo-controlled, parallel-group, pragmatic clinical trial

Zhiyao Chen(Heilongjiang University of Chinese Medicine), Qing Xia(Sichuan University), Dan Du(Sichuan University), Yanqiu He(Sichuan University), Xiaonan Yang(Jiangsu University), Fei Cai(Sichuan University), Xin Sun(Jilin University), Cheng Hu(Sichuan University), Jing Li(Sichuan University), Lan Li(North China University of Science and Technology), Ling Li(Shihezi University), Tao Jin(Sichuan University), Kun Jiang(Sichuan University), Jia Guo(Chinese Academy of Agricultural Sciences), Wei Huang(Sichuan University), Lihui Deng(Sichuan University), Ping Zhu(Sichuan University), Qingyuan Tan(Sichuan University)
Trials
November 8, 2022
Cited by 10


Related Papers